Recruiting
Phase 1

Sponsor:

SillaJen, Inc.

Code:

NCT05768932

Conditions

Advanced Solid Tumor

TNBC - Triple-Negative Breast Cancer

Gastric Cancer

Leukemia Acute Myeloid Leukemia (AML)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BAL0891

Carboplatin

Paclitaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by SillaJen, Inc. on 2025-04-03.